Browse studies, page 131
Page 131 of 1,286, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- New Therapeutics for Chagas Disease: Charting a Course to Drug Approval IntechOpen eBooks, 2022
- Tropical infectious diseases and the skin: Diagnostic and treatment updates since the WHO's integrated campaign against neglected tropical skin diseases Dermatological Reviews, 2023
- Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives ACS Omega, 2024
- Intra-host Trypanosoma cruzi strain dynamics shape disease progression: the missing link in Chagas disease pathogenesis Microbiology Spectrum, 2023
- In Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, a Potential Novel Compound for Treating against Trypanosoma cruzi Pathogens, 2022
- Metabolomic profiling for the identification of drug targets in trypanosomes Frontiers in Chemical Biology, 2026
- Chagas Disease: From Discovery to a Worldwide Health Problem Frontiers in Public Health, 2019
- Enteric nervous system regeneration and functional cure of experimental digestive Chagas disease with trypanocidal chemotherapy Nature Communications, 2024
- Fungi’s Swiss Army Knife: Pleiotropic Effect of Melanin in Fungal Pathogenesis during Cattle Mycosis Journal of Fungi, 2023
- Possibility of re-purposing antifungal drugs posaconazole & isavuconazole against promastigote form of Leishmania major The Indian Journal of Medical Research, 2024
- Chagas Disease Drug Discovery in Latin America—A Mini Review of Antiparasitic Agents Explored Between 2010 and 2021 Frontiers in Chemistry, 2021
- Drug repurposing for Chagas disease: In vitro assessment of nimesulide against Trypanosoma cruzi and insights on its mechanisms of action PLoS ONE, 2021
- Structure-Guided Design and Synthesis of a Pyridazinone Series of Trypanosoma cruzi Proteasome Inhibitors Journal of Medicinal Chemistry, 2023
- Sandalwood Sesquiterpene (Z)-α-Santalol Exhibits In Vivo Efficacy Against Madurella mycetomatis in Galleria mellonella Larvae Molecules, 2025
- The translational challenge in Chagas disease drug development Memórias do Instituto Oswaldo Cruz, 2022
- Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease Pharmaceutics, 2022
- Advancing topical posaconazole delivery: BOX behnken design microsponge hydrogel optimization and extensive in vivo investigation International Journal of Applied Pharmaceutics, 2024
- Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure PLoS neglected tropical diseases, 2022
- Pyrazole-Imidazoline Derivative Prevents Cardiac Damage and Mortality in Acute Trypanosoma cruzi Infection Pharmaceuticals, 2025
- Preclinical data do not support the use of amiodarone or dronedarone as antiparasitic drugs for Chagas disease at the approved human dosing regimen Frontiers in Tropical Diseases, 2023
- Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases? Frontiers in Cellular and Infection Microbiology, 2022
- Mechanisms of resistance against allylamine and azole antifungals in Trichophyton: A renewed call for innovative molecular diagnostics in susceptibility testing PLoS Pathogens, 2025
- Perspectives for a new drug candidate for Chagas disease therapy Memórias do Instituto Oswaldo Cruz, 2022
- The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in Africa Medical Mycology, 2023
- Localized cardiac small molecule trajectories and persistent chemical sequelae in experimental Chagas disease Nature Communications, 2023
- Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain Pathogens, 2021
- Screening of synthetic 1,2,3-triazolic compounds inspired by SRPIN340 as anti-Trypanosoma cruzi agents Revista da Sociedade Brasileira de Medicina Tropical, 2024
- A profile of research on the parasitic trypanosomatids and the diseases they cause PLoS neglected tropical diseases, 2022
- Precision Health for Chagas Disease: Integrating Parasite and Host Factors to Predict Outcome of Infection and Response to Therapy Frontiers in Cellular and Infection Microbiology, 2020
- Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease European Journal of Medicinal Chemistry, 2022
- Antifungal Combinations against Candida Species: From Bench to Bedside Journal of Fungi, 2022
- Amiodarone and Ravuconazole Combination Potentiates Chemotherapy against Drug-Resistant Trypanosoma cruzi Strains ACS Omega, 2025
- Short-course combination treatment for experimental chronic Chagas disease Science Translational Medicine, 2023
- In vitro susceptibility testing for black grain eumycetoma causative agents Transactions of the Royal Society of Tropical Medicine and Hygiene, 2020
- Bioactivity of Novel Pyrazole-Thiazolines Scaffolds against Trypanosoma cruzi: Computational Approaches and 3D Spheroid Model on Drug Discovery for Chagas Disease Pharmaceutics, 2022
- IID432, a parasite-selective topoisomerase II inhibitor, achieves rapid single-dose parasite clearance in a murine chronic Chagas model Proceedings of the National Academy of Sciences, 2026
- Antitrypanosomal Activity of 1,2,3-Triazole-Based Hybrids Evaluated Using In Vitro Preclinical Translational Models Biology, 2023
- Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy PLoS neglected tropical diseases, 2023
- Pharmacokinetic-pharmacodynamic modeling of benznidazole and its antitrypanosomal activity in a murine model of chronic Chagas disease PLoS neglected tropical diseases, 2025
- P4 COVID19-associated fungal infections Medical Mycology, 2022
- Global health initiatives and mycetoma management: the unmet promise Transactions of the Royal Society of Tropical Medicine and Hygiene, 2025
- S5.1b Antifungal r esistance Medical Mycology, 2022
- Topical Antifungal Therapy Combined with Nail Abrasion for the Treatment of Dermatophytoma: Single-Center Results — A Secondary Publication Dermatological Health, 2024
- Epidemiology, clinical features, and outcome of the hospitalized patients with Kerion in Fars Province, Iran: an eleven-year retrospective study BMC Pediatrics, 2024
- Antifungal susceptibility pattern of Candida isolated from cutaneous candidiasis patients in eastern Guangdong region: A retrospective study of the past 10 years Frontiers in Microbiology, 2022
- Case Report: Reactivation of Chagas disease in a patient with advanced HIV 15 Years after migration Frontiers in Tropical Diseases, 2025
- Assessing antibody decline after chemotherapy of early chronic Chagas disease patients Parasites & Vectors, 2021
- Parasitemia and antibody response to benznidazole treatment in a cohort of patients with chronic Chagas disease Frontiers in Parasitology, 2023
- In Vitro Ravuconazole Susceptibility of Anthropophilic Dermatophyte Strains Isolated from Japanese Patients Japanese Journal of Infectious Diseases, 2019
- Distribution and antifungal susceptibility profiles of candida species isolated from dermatomycosis patients Journal of Health Sciences and Medicine, 2024
- What Can Imaging Do for Mycetoma in an Immunocompetent Patient in Temperate Region Journal of Radiology Case Reports, 2025
- Population pharmacokinetic modeling of benznidazole in Brazilian patients with chronic Chagas disease Revista do Instituto de Medicina Tropical de São Paulo, 2022
- Why the mycetoma patients are still neglected PLoS neglected tropical diseases, 2022
- Combating Multidrug-Resistant Acinetobacter baumannii: Insights from Japan, with Global Relevance Dove Medical Press (Taylor and Francis Group), 2025
- Tinea capitis in Older Adults: A Neglected and Misdiagnosed Scalp Infection—A Systematic Review of Reported Cases Antibiotics, 2025
- Pyrazoline-Based Molecules In Antimicrobial Research: A Systematic Review International Journal of Environmental Sciences, 2025
- Impact of antiparasitic therapy on cardiovascular outcomes in chronic Chagas disease. A systematic review and meta-analysis EClinicalMedicine, 2024
- Screening for Trypanosoma cruzi infection in immigrants and refugees: Systematic review and recommendations from the Spanish Society of Infectious Diseases and Clinical Microbiology Eurosurveillance, 2020
- Use of benznidazole to treat chronic Chagas disease: An updated systematic review with a meta-analysis PLoS neglected tropical diseases, 2022
- Fungal Melanonychia: A Systematic Review Microorganisms, 2024
- Nail dystrophy caused by infectious skin diseases: a narrative review Journal of Korean Medical Association, 2025
- Ring of Fire: The Global Rise of Drug Resistant Ringworm and the Race to Outpace It: A Narrative Review of Dermatophytosis and Emerging Antifungal Resistance INDIAN JOURNAL OF ALLIED HEALTH SCIENCE, 2026
- WHF IASC Roadmap on Chagas Disease Global heart, 2020
- Experimental and Clinical Treatment of Chagas Disease: A Review The American journal of tropical medicine and hygiene, 2017
- Onychomycosis: An Updated Review Recent patents on inflammation & allergy drug discovery, 2020
- Phaeohyphomycosis in China Frontiers in cellular and infection microbiology, 2022
- Challenges and recent progress in drug discovery for tropical diseases Nature, 2018
- Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates Biomolecules, 2023
- Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States PLoS neglected tropical diseases, 2019
- Novel 1, 2, 4-Triazoles as Antifungal Agents BioMed research international, 2022
- New Antifungal Agents with Azole Moieties Pharmaceuticals (Basel, Switzerland), 2022
- Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need Nature reviews. Microbiology, 2017
- Anti-trypanosomatid drug discovery: progress and challenges Nature reviews. Microbiology, 2023
- Plant Terpenoids as Hit Compounds against Trypanosomiasis Pharmaceuticals (Basel, Switzerland), 2022
- Antifungal activity and mechanism of action of natural product derivates as potential environmental disinfectants Journal of industrial microbiology & biotechnology, 2023
- Skin Disease in the Tropics and the Lessons that can be Learned from Leprosy and Other Neglected Diseases Acta dermato-venereologica, 2020
- Discovery, Development, Inventions and Patent Review of Fexinidazole: The First All-Oral Therapy for Human African Trypanosomiasis Pharmaceuticals (Basel, Switzerland), 2022
- TrypPROTACs Unlocking New Therapeutic Strategies for Chagas Disease Pharmaceuticals (Basel, Switzerland), 2025
- Chagas Disease: Perspectives on the Past and Present and Challenges in Drug Discovery Molecules (Basel, Switzerland), 2020
- State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation Research and reports in tropical medicine, 2023
- Uncovering the Mechanism of Action of Antiprotozoal Agents: A Survey on Photoaffinity Labeling Strategy Pharmaceuticals (Basel, Switzerland), 2024
- Antifungal Resistance in Dermatophytes: Genetic Considerations, Clinical Presentations and Alternative Therapies Journal of fungi (Basel, Switzerland), 2021
- Potential Strategies to Control the Risk of Antifungal Resistance in Humans: A Comprehensive Review Antibiotics (Basel, Switzerland), 2023
- Antifungal Natural Products Originating from Endophytic and Rhizospheric Microbes Isolated from Coastal Vegetation Journal of xenobiotics, 2025
- Aminopyridines in the development of drug candidates against protozoan neglected tropical diseases Future medicinal chemistry, 2024
- Mycetoma: Development of Diagnosis and Treatment Journal of fungi (Basel, Switzerland), 2022
- Chagas Disease: A Silent Threat for Dogs and Humans International journal of molecular sciences, 2024
- The potential role and mechanism of circRNA/miRNA axis in cholesterol synthesis International journal of biological sciences, 2023
- The Antifungal Potential of Niclosamide and Structurally Related Salicylanilides International journal of molecular sciences, 2024
- A Review of Antifungal Susceptibility Testing for Dermatophyte Fungi and It's Correlation with Previous Exposure and Clinical Responses Journal of fungi (Basel, Switzerland), 2022
- System-based insights into parasitological and clinical treatment failure in Chagas disease mSystems, 2025
- Ungual hyalohyphomycosis caused by Fusarium cugenangense Clinical case reports, 2020
- Mycetomas: an epidemiological, etiological, clinical, laboratory and therapeutic review Anais brasileiros de dermatologia, 2018
- Mycetoma: A Common Yet Unrecognized Health Burden in Central India Indian dermatology online journal, 2019
- Molecular Epidemiology and Antifungal Susceptibility of Trichophyton Isolates in Greece: Emergence of Terbinafine-Resistant Trichophytonmentagrophytes Type VIII Locally and Globally Journal of fungi (Basel, Switzerland), 2021
- Clinical Features of Mycetoma and the Appropriate Treatment Options Research and reports in tropical medicine, 2021
- Onychomycosis Caused by Fusarium Species Journal of fungi (Basel, Switzerland), 2022
- Nail Society of India Recommendations for Treatment of Onychomycosis in Special Population Groups Indian dermatology online journal, 2024
- An updated list of eumycetoma causative agents and their differences in grain formation and treatment response Clinical microbiology reviews, 2024
- Dioxin exposure and breast cancer risk in a prospective cohort study Environmental Research, 2020
